Last Chance to Apply for Research Grants + International Visiting Scholarship
The deadline for current ISHLT funding opportunities is quickly approaching. Applications for three industry-supported research grants (funded through the ISHLT Foundation) and the new International Visiting Scholarship will close on Tuesday, 30 September at 11:59 p.m. ET / Wednesday, 1 October at 03:59 UTC.
ISHLT International Visiting Scholarship
The newly revised International Visiting Scholarship will facilitate the exchange of knowledge and skillsets related to advanced heart and lung diseases and their treatments (e.g., heart and lung transplantation). The scholarship can be used to send an individual to a selected institution to learn OR to bring someone from the selected institution to the recipient’s institution to teach.
ISHLT Acellular Ex Vivo Lung Perfusion (EVLP) Research Grant
Supported by Lung Bioengineering
Grant Amount: Up to $37,500 USD for one year
The purpose of this grant is to fund research that aims to develop further advancements in acellular Ex Vivo Lung Perfusion (EVLP) technology. This could include various aspects, including optimization of perfusion techniques, intervention and repair strategies, immunomodulation and reconditioning, and outcomes research.
ISHLT Cardiogenic Shock Research Grant
Supported by Johnson & Johnson MedTech | Heart Recovery
Grant Amount: Up to $140,000 USD for two years
The purpose of this grant is to support research that would enhance the understanding and management of cardiogenic shock in the setting of heart failure to optimize clinical outcomes and promote native heart recovery using temporary mechanical circulatory support (tMCS).
ISHLT Molecular Biomarker Study Using Artificial Intelligence/Machine Learning Analysis in Lung Transplantation
Supported by CareDx, Inc.
Grant Amount: Up to $40,000 USD for one year
The purpose of this grant is to fund research that utilizes the support of Artificial Intelligence/Machine Learning in addition to blood, body fluid or tissue-based molecular biomarkers to improve access and/or clinical outcomes in lung transplantation.